权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Development of a Novel Inhibitor of Enterovirus Replication

新型肠道病毒复制抑制剂的开发

基本信息

批准号：
8702945
负责人：
PAUL A KROGSTAD
金额：
$ 23.1万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-06-15 至 2016-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8702945
关键词：
Acute Affinity Antiviral Agents Asia Biological Assay Blood Circulation California Cambodia Central Nervous System Infections Cessation of life Core Facility Coxsackie B Viruses Coxsackie Viruses Coxsackievirus Infections Development Disease Disease Outbreaks Echo Viruses Encephalitis Enterovirus Enterovirus 71 Enterovirus Infections Epidemic Europe Exhibits Goals Hand, Foot and Mouth Disease Health Care Costs Heart Heart failure Hepatitis Hospitalization Human Human poliovirus Immunization Infection Institutes Lead Life Link Molecular Morbidity - disease rate Myocarditis Newborn Infant North America Pharmaceutical Preparations Play Poliomyelitis Polioviruses Process RNA Viruses Reporting Resource Sharing Respiratory Tract Infections Role Sepsis Site Techniques United States Variant Viral Viral Epidemiology Virus Work inhibitor/antagonist innovation mortality nanosystems novel pathogen public health relevance pyridine screening small molecule

项目摘要

DESCRIPTION (provided by applicant): Enteroviruses are small, non-enveloped RNA viruses responsible for poliomyelitis, encephalitis, acute heart failure or severe hepatitis in newborns, and other life threatening infections. In the United States recent outbreaks of coxsackievirus B1 (CVB1) infections and coxsackievirus A6 served as reminders of the ongoing threat raised by these pathogens. Similarly, outbreaks of enterovirus 71 have occurred nearly annually in Europe and the Asia-Pacific region for almost 20 years, and could potentially lead to epidemics in North America if imported. We have recently identified a novel group of closely related small molecules that inhibit the replication of coxsackievirus B (CVB) variants, polioviruses, and other enteroviruses. We propose a two-year study to identify derivatives of this group of compounds with robust antiviral activity against pathogenic enteroviruses. Successful completion of these goals could ultimately lead to the development of antiviral drugs useful in cases of life-threatening enterovirus infections and that could potentially play a role in the eradication of poliovirus circulation.

性状（由申请方提供）：肠道病毒是一种小型无包膜RNA病毒，可引起脊髓灰质炎、脑炎、急性心力衰竭或新生儿重度肝炎以及其他危及生命的感染。在美国，最近爆发的柯萨奇病毒B1（CVB1）感染和柯萨奇病毒A6提醒人们注意这些病原体带来的持续威胁。同样，近20年来，欧洲和亚太地区几乎每年都发生肠道病毒71型的暴发，如果输入，可能导致北美的流行病。我们最近发现了一组新的密切相关的小分子，抑制柯萨奇病毒B（CVB）变异体，脊髓灰质炎病毒和其他肠道病毒的复制。我们提出了一个为期两年的研究，以确定这组化合物的衍生物具有强大的抗病原性肠道病毒的抗病毒活性。这些目标的成功实现可能最终导致抗病毒药物的开发，这些药物可用于危及生命的肠道病毒感染，并可能在根除脊髓灰质炎病毒传播中发挥作用。